Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 1 OF 13 | DISPLAYING 1 - 15 OF 182 RESULTS

    Annels NE et al., Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21., , Clin Cancer Res, Jul 04, 2019

    Van TM et al., A user's perspective on GeoMx digital spatial profiling, , Immuno-Oncology Technology, Jul 01, 2019

    Wu F et al., Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer, , Int. J. Mol. Sci., Jun 24, 2019

    Beck TN et al., Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer., , BMC Cancer, Jun 19, 2019

    Jaeger AM et al., Rebalancing protein homeostasis enhances tumor antigen presentation., , Clin Cancer Res, Jun 18, 2019

    Wang Z et al., Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of in situ anti-CTLA-4, , bioRxiv, Jun 15, 2019

    Rozenblit M et al., Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod., , Sci Rep, Jun 12, 2019

    Monteiro AC et al., Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma., , Mol Oncol., May 23, 2019

    Ragulan C et al., Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes., , Sci Rep, May 21, 2019

    Ndreshkjana B et al., Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells, , Cell Death & Disease, May 16, 2019

    Monteiro AC et al., Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma, , Mol Oncol., May 08, 2019

    Waks AG et al., The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy., , Clin Cancer Res. , May 06, 2019

    Vázquez-Arreguín K et al., Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy, , PLoS Genet., May 06, 2019

    Allen CT et al., Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis, , J Immunother Cancer, May 03, 2019

    Perez-Ruiz E et al., Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy, , Nature, May 01, 2019